Dopamine agonists and pathological gambling

Parkinsonism and Related Disorders

Volumn 13, Issue 4, 2007, Pages 259-

  Grosset, K A ^a   Macphee, G ^a   Pal, G ^b   Stewart, D ^c   Watt, A ^d   Davie, J ^e   Grosset, D G ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b Monklands Hospital   (United Kingdom)

^c VICTORIA INFIRMARY   (United Kingdom)

^d AYR HOSPITAL   (United Kingdom)

^e STOBHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

COMPARATIVE STUDY; DISEASE DURATION; DISEASE SEVERITY; HUMAN; LETTER; MEDICAL LITERATURE; MEDICAL RESEARCH; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; RISK ASSESSMENT;

DOPAMINE AGONISTS; GAMBLING; HUMANS; PARKINSON DISEASE;

EID: 34247143444     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2006.08.003     Document Type: Letter

References (6)

1. Imamura A., Uitti R.J., and Wszolek Z.K. Dopamine agonist therapy for Parkinson disease and pathological gambling. Parkinsonism Relat Disord 12 8 (2006) 506-508
2. Molina JA, Sainz-Artiga MJ, Fraile A, Jimenez-Jimenez FJ, Villanueva C, Orti-Pareja M, et al. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment? Movement Disord 2000;15(5): 869-72.
3. Grosset K.A., MacPhee G., Pal G., Stewart D., Watt A., Davie J., et al. Problematic gambling on dopamine agonists: not such a rarity. Movement Disord (2006) in press
4. Lu C., Bharmal A., and Suchowersky O. Gambling and Parkinson disease. Arch Neurol 63 2 (2006) 298
5. Voon V., Hassan K., Zurowski M., Duff-Canning S., de Souza M., Fox S., et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 66 11 (2006) 1750-1752
6. Driver-Dunckley E., Samanta J., and Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 61 3 (2003) 422-423